Advertisement
Review Article| Volume 40, ISSUE 3, P317-329, September 2020

Reference Laboratory Testing for Neurologic Disorders

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Carter E.
        • Bennett B.D.
        Reference test review by pathology house staff: a cost-containment strategy for the clinical laboratory.
        Clin Leadersh Manag Rev. 2002; 16: 3-6
        • Dickerson J.A.
        • Cole B.
        • Conta J.H.
        • et al.
        Improving the value of costly genetic reference laboratory testing with active utilization management.
        Arch Pathol Lab Med. 2014; 138: 110-113
        • Valenstein P.N.
        • Walsh M.K.
        • Stankovic A.K.
        Accuracy of send-out test ordering: a college of American pathologists Q-probes study of ordering accuracy in 97 clinical laboratories.
        Arch Pathol Lab Med. 2008; 132: 206-210
        • Krasowski M.D.
        • Chudzik D.
        • Dolezal A.
        • et al.
        Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center.
        BMC Med Inform Decis Mak. 2015; 15: 1-10
        • Baird G.S.
        • Jackson B.R.
        • Dickerson J.
        • et al.
        What’s new in laboratory test utilization management?.
        Clin Chem. 2018; 64: 994-1000
        • Zhi M.
        • Ding E.L.
        • Theisen-Toupal J.
        • et al.
        The landscape of inappropriate laboratory testing: a 15-year meta-analysis.
        PLoS One. 2013; 8: 1-8
        • Bindraban R.S.
        • ten Berg M.J.
        • Naaktgeboren C.A.
        • et al.
        Reducing test utilization in hospital settings: a narrative review.
        Ann Lab Med. 2018; 38: 402-412
        • Jakacka N.
        • Snarski E.
        • Mekuria S.
        Prevention of iatrogenic anemia in critical and neonatal care.
        Adv Clin Exp Med. 2016; 25: 191-197
        • Signorelli H.
        • Straseski J.A.
        • Genzen J.R.
        • et al.
        Benchmarking to identify practice variation in test ordering: a potential tool for utilization management.
        Lab Med. 2015; 46: 356-364
        • Lewandrowski K.
        Integrating decision support into a laboratory utilization management program.
        Clin Lab Med. 2019; 39: 245-257
        • Costain G.
        • Cordeiro D.
        • Matviychuk D.
        • et al.
        Clinical application of targeted next-generation sequencing panels and whole exome sequencing in childhood epilepsy.
        Neuroscience. 2019; 418: 291-310
        • Renton A.E.
        • Majounie E.
        • Waite A.
        • et al.
        A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.
        Neuron. 2011; 72: 257-268
        • DeJesus-Hernandez M.
        • Mackenzie I.R.
        • Boeve B.F.
        • et al.
        Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
        Neuron. 2011; 72: 245-256
        • López-Chiriboga A.S.
        • Flanagan E.P.
        Diagnostic and therapeutic approach to autoimmune neurologic disorders.
        Semin Neurol. 2018; 38: 392-402
        • Ebright M.J.
        • Li S.H.
        • Reynolds E.
        • et al.
        Unintended consequences of Mayo paraneoplastic evaluations.
        Neurology. 2018; 91: e2057-e2066
      1. Heavy metals panel, blood. Quest diagnostics.
        (Available at:) (Accessed December 17, 2019)
      2. Paraneoplastic evaluation algorithm. Mayo clinic laboratories.
        (Available at:) (Accessed December 17, 2019)
      3. Encephalopathy evaluation algorithm, Mayo clinic laboratories.
        (Available at:) (Accessed December 17, 2019)
        • van Walraven C.
        • Naylor D.
        Do we now know what inappropriate laboratory utilization is? An expanded systematic review of laboratory clinical audits.
        JAMA. 1998; 280: 550-558
        • Kim J.Y.
        • Dzik W.H.
        • Dighe A.S.
        • et al.
        Utilization management in a large urban academic medical center: a 10-year experience.
        Am J Clin Pathol. 2011; 135: 108-118
        • Harb R.
        • Hajdasz D.
        • Landry M.L.
        • et al.
        Improving laboratory test utilisation at the multihospital yale new haven health system.
        BMJ Open Qual. 2019; 8: e000689
        • Warren J.S.
        Laboratory test utilization program: structure and impact in a large academic medical center.
        Am J Clin Pathol. 2013; 139: 289-297
        • Feldman L.S.
        • Shihab H.M.
        • Thiemann D.
        • et al.
        Impact of providing fee data on laboratory test ordering: a controlled clinical trial.
        JAMA Intern Med. 2013; 173: 903-908
        • Horn D.M.
        • Koplan K.E.
        • Senese M.D.
        • et al.
        The impact of cost displays on primary care physician laboratory test ordering.
        J Gen Intern Med. 2014; 29: 708-714
        • Sedrak M.S.
        • Myers J.S.
        • Small D.S.
        • et al.
        Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests: the PRICE randomized clinical trial.
        JAMA Intern Med. 2017; 177: 939-945
        • Goetz C.
        • Rotman S.R.
        • Hartoularos G.
        • et al.
        The effect of charge display on cost of care and physician practice behaviors: a systematic review.
        J Gen Intern Med. 2015; 30: 835-842